![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, March 12, 2023 3:47:54 PM
Bottom line is there is still a need and there is currently the fewest drugs available to treat iCovid since the first drugs were given an EUA. Add in the fact that no one wants the vaccines anymore and there is still a big opportunity for Revive. We have an extremely safe drug with strong science that shows it should work and work extremely well. We unfortunately also have an extremely small company with three actual employees that have made many mistakes along the way as they try to compete on the big stage. Revive is squarely still in the game and there are certainly still hurdles left to cross over but the risk reward here is as good as it gets especially at these prices. The FDA has given the go ahead for the EP change, Revive just needs to send in the protocol as the FDA stated and we will be looking at symptoms as an endpoint. The DSMB will be shortly after where we will finally see the data. If you believe in the science and opportunity shut out the noise and maybe avg down. If you don’t believe in the science sell your position, take the L and go buy some crypto; it’s still cheap!
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM